luspatarcept
bms
['mds']
 the stratification about the 3 different 'types' of sf3b1 is fascinating.
would love to see this applied to use of #luspatercept data, to perhaps reduce the uncertainty of efficacy, and have impact on price of the drug?
is this planned ?
#mdssm
#eha2022
UK charity for blood cancer Myelodysplastic Syndromes & CMML Support, advocacy, info for patients/carers/staff. 
#nhscrisis=personal views #NHSLOVE